How comparing works here
How do I compare two companies?
Type the tickers into the box above — up to five at once. Every row is read from the companies' own annual filings, so a comparison shows the same measure computed the same way for each of them rather than whatever each company chose to highlight.
Can I compare an ETF with a stock?
Yes, and the table changes to suit. Two funds are compared on cost, income, spread and record, because revenue growth and debt mean nothing for a fund. A fund against a company shows only what both of them have.
Side by side
Compare
Put up to 4 companies, funds, commodities or coins next to each other — health, valuation, growth and performance.
Every row is computed the same way for every column, from each company's own annual filing, so a comparison is not a collection of whichever figures each of them chose to put in a press release. Funds are compared on what a fund is actually judged on: cost, income, spread and record.
Relative performance
Rebased so every symbol starts at 0%
Loading price history…
Side by side
Latest annual figures from each company's filings
| Metric | DVADAVITA INC. | DGXQUEST DIAGNOSTICS INC | LHLABCORP HOLDINGS INC. | GHGuardant Health, Inc. | Median of the restexcluding DVA |
|---|---|---|---|---|---|
| Type | Company | Company | Company | Company | |
| Price | $175.35▼ 11.65 (6.23%) | $243.28▲ 4.35 (1.82%) | $329.93▲ 6.18 (1.91%) | $162.94▼ 3.72 (2.23%) | |
| Health scoreComposite of profitability, growth, debt and accounting quality. | 4.7/10 | 8.0/10 | 7.0/10 | 6.0/10 | 7.0/10 |
| Market value | $12.02B | $27.00B | $27.12B | $21.29B | |
| Revenue | $13.64B | $11.04B | $13.95B | $982.0M | |
| Profit | $746.8M | $992.0M | $876.5M | -$416.3M | |
| Revenue growthChange in sales versus the prior year. | 6.5% | 11.8% | 7.2% | 32.9% | 11.8% |
| Gross marginShare of sales left after the direct cost of producing them. | — | 33.2% | 28.8% | 64.5% | 33.2% |
| Operating marginShare of sales left after running the business, before interest and tax. | 15.0% | 14.1% | 9.9% | -44.5% | 9.9% |
| Profit marginProfit kept from each dollar of sales. | 5.5% | 9.0% | 6.3% | -42.4% | 6.3% |
| Free cash flow marginCash left after capital spending, as a share of sales. | 9.6% | 12.3% | 8.6% | -23.7% | 8.6% |
| Return on equityProfit against the owners' stake in the company. | -114.7% | 13.8% | 10.2% | 419.2% | 13.8% |
| Return on invested capital (approx.)Operating profit after tax against equity plus debt, less cash. Cash here excludes short-term investments, so this runs low for cash-rich companies. | 12.7% | 9.4% | 8.0% | -33.7% | 8.0% |
| P/E ratioPrice paid per dollar of annual profit. | 16.10x | 27.22x | 30.94x | — | 29.08x |
| EV / EBITDA (approx.)Market value plus debt less cash, against operating profit before depreciation. Cash excludes short-term investments, so this runs high for cash-rich companies. | 7.86x | 15.17x | 15.57x | — | 15.37x |
| Price to book | -18.46x | 3.77x | 3.15x | -214.34x | 3.15x |
| Debt to equityTotal liabilities compared with owners' stake. | -25.07x | 1.26x | 1.13x | -21.28x | 1.13x |
| Piotroski F-ScoreNine checks of financial strength. Higher is stronger. | 6/8 | 8/9 | 8/9 | 5/9 | 8.0 |
| Bankruptcy riskAltman Z-Score zone. | distress | safe | safe | distress |
How DVA compares with the others
- DVA's operating margin of 15.0% is higher than the median of the other companies selected (9.9%).
- Its revenue grew more slowly than the median of the other companies selected: 6.5% against 11.8%.
- It trades at a lower P/E than the median of the other companies selected: 16.1x against 29.1x.
- Its liabilities are lower relative to equity than the median of the other companies selected: -25.1x against 1.1x.
Measured against the other companies entered, from each one's latest annual filing. A difference describes the companies; it does not rank them.